NHS National Innovation Centre

Stand number: 49

 

NHS National Innovation Centre - ‘The National Innovation Centre, for a healthier future’

The National Innovation Centre is a DH Centre of Excellence that supports innovators from across the innovation landscape and advises the DH on commissioning innovation. 

Showcase Content:

Showcasing cutting edge Healthcare technology and innovation commissioning systems.

On the NIC stand you will see several leading innovations that will deliver value to both the NHS and the patient.  These are:

• A hand-held non-invasive blood glucose meter for use by  people with diabetes,
• a minimally-invasive process now being used successfully in  the NHS for treating varicose veins
• a rapid, point-of-care test for diagnosing MRSA
• An interactive web based application providing training in  venepuncture. The lifelike simulation gives the trainee tactile  and informative feedback on their performance.
• An interactive display of the DH’s leading edge web-based  innovation commissioning tools.  The NIC’s new web site with  innovation commissioning tools and Innovations Showcase will  be launched at EXPO on 18th June

Contact:

National Innovation Centre,  Marie Maher at Marie.Maher@institute.nhs.uk

Lein Applied Diagnostics, Dr Dan Daly at dan.daly@lein-ad.com

VNUS Medical Technology UK Ltd, Mike Branagan-Harris at  mharris@vnus.com

TwistDX, Dr Niall Armes at  naill@twistdx.co.uk

UK Haptics, Dr Gary Todd at  gary@ukhaptics.co.uk

Partners:

Lein Applied Daignostics

Lein Applied Diagnostics, a research company pioneering innovative solutions for the healthcare market. Its primary research focus is non-invasive diagnostics and measurement via the eye, with a view to developing products for both healthcare professionals and the consumer. Key to this is its use of novel optical, electrical and mechanical technologies to overcome the challenges in developing the next generation of non-invasive medical devices to meet the rising demand for point of care testing. 
http://www.lein-ad.com  

TwistDX

TwistDx is developing novel diagnostic tests based on a new, breakthrough isothermal DNA amplification technology.  These tests will be more rapid and portable than current DNA diagnostics while being highly specific and exquisitely sensitive, ultimately enabling the use and benefit of DNA diagnostics globally and in all settings.
TwistDx’s revolutionary technology, Recombinase Polymerase Amplification (RPA), is positioned to become the DNA-based diagnostic platform of the future, with wide-ranging applications in a number of fields, including medical diagnostics, veterinary medicine, industrial applications, agriculture, public health and biosecurity and environmental sensing.
www.twistdx.co.uk

VNUS Medical Technology UK Ltd

VNUS Medical Technologies UK Ltd was founded in 1995, is a public company and world leader in the development and commercialization of products for minimally invasive treatment of venous disease. The company currently markets the proprietary closure system of products for patients who suffer from symptoms associated with venous reflux. The Closure system was first used in Europe beginning in 1998 and cleared for marketing in the U.S. in March 1999. Since then, over 350,000 patients worldwide have received the Closure procedure and numerous studies have shown the Closure procedure can provide substantial benefits to eligible patients with venous disease.
www.vnus.co.uk

UK Haptics

UK Haptics develop virtual reality training solutions for practice based learning and skills rehearsal in medical and clinical situations using 3D virtual environments to create life like simulations. The simulations take place in real time and provide testing together with user feedback with clinical metrics.
‘Haptics’ is defined as ‘tactile sensation applied to computer applications’ that translate into software that enables users to ‘feel’ their interaction with the computer program.
www.ukhaptics.co.uk